KLIFO A/S: Financial statements 2019
CVR: 18196131
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
KLIFO A/S (CVR 18196131) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 81,067,000 and a net result of DKK -263,000 compared with DKK 7,440,071 the year before. That is an increase of 15.7% compared with the year before. Equity in the 2019 report amounted to DKK 14,935,000. The solvency ratio was 30.9%. The company had 97 employees in the financial year.
- Gross Profit
- DKK 81,067,000
- Profit/Loss
- DKK -263,000
- Equity
- DKK 14,935,000
- Total Assets
- DKK 48,260,000
- Employees
- 97
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 81.1M | -263K | 14.9M | 97 |
| 2018 | - | 70.1M | 7.4M | 18.9M | 73 |
| 2017 | - | 57.3M | 7.3M | - | 56 |
| 2016 | - | 37.4M | 3.9M | 9.8M | 40 |
| 2015 | - | 28M | 2.7M | 7.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
KLIFO A/S has published its annual report for 2018. Gross profit came to DKK 70,084,547, and the net result was DKK 7,440,071.
About KLIFO A/S
KLIFO A/S is a Danish company of the type Aktieselskab based in Brøndby, founded in 1994. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of René Holmen Pedersen. The board consists of Niels Peder Nielsen (chair), Alejandra Maria Cristina Bonifacini Mørk, Rafael Natanek and Redmar Koene. The company is owned by Drug Development Consulting BidCo ApS. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 84,066,000 and a net result of DKK -47,419,000 compared with DKK -128,000 the year before. Equity in the 2025 report amounted to DKK 16,135,000.